Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Fujisawa reports collagenase inhibitors

May 3, 1996

Searle and Yamanouchi to codevelop celecoxib

April 26, 1996

Hisamitsu discloses new cyclooxygenase inhibitor

April 26, 1996

Nihon Iyakuhin's NSAID research bears fruit

April 26, 1996

TNF-bp in clinical testing

April 19, 1996

Amiprilose advances to phase III in rheumatoid arthritis

April 12, 1996

COX-2 inhibitor research continues at Merck Frosst

April 12, 1996

PEG-rhSOD advancing in preclinical phase

April 5, 1996

Colloral dose refinement study underway

March 15, 1996

Lilly reports drugs for osteoarthritis

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...